Completed PHASE1 INTERVENTIONAL 2-arm NCT00763841

Transcranial Magnetic Stimulation (TMS) for Treatment of Auditory Hallucinations

A Pilot Study Using Transcranial Magnetic Stimulation (TMS) to Investigate the Role of the Temporal Cortex in Schizophrenic Patients With Auditory Hallucinations

Sponsor: NSW Schizophrenia Fellowship

Conditions Auditory Hallucinations

Interventions Sham Transcranial magnetic stimulation

Updated 5 times since 2017 Last updated: Jan 19, 2010 Started: Sep 30, 1999 Primary completion: Sep 30, 2008 Completion: Sep 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00763841, this PHASE1 trial focuses on Auditory Hallucinations and remains completed. Sponsored by NSW Schizophrenia Fellowship, it has been updated 5 times since 1999, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Sep 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

NSW Schizophrenia Fellowship
Rebecca Cooper Medical Research Foundation
The University of New South Wales

Data source: The University of New South Wales

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sydney, Australia